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Introduction
Membrane proteins have to be inserted cotranslationally into the endoplasmic reticulum. This occurs via the translocon, a channel formed by the Sec61-subunits. During and after synthesis of membrane proteins in the endoplasmic reticulum, they undergo a strict quality control to ensure correct folding, before they are transported to their definitive site of action. Several aspects of this quality control are incompletely understood; nevertheless it is clear that incorrect folding of a membrane protein is sensed by the machinery of the endoplasmic reticulum (that is by chaperons, presumably). This leads to activation of ubiquitinating enzymes on the cytoplasmic side. These transfer ubiquitin to the cytoplasmic peptide chain of the incorrectly folded protein, which is retrotranslocated and degraded by the 26S proteasome (Kostova and Wolf, 2003) . This scheme relies predominantly on observations that were made in Saccharomyces cervisiae. Based on several pieces of experimental evidence, it is, however, reasonable to assume that higher eukaryotes employ a related machinery to eliminate misfolded proteins (Lilley and Ploegh 2004; Ye et al., 2004) .
It has been increasingly appreciated that many human diseases can be linked to mutations, which result in the retention of the aberrant protein in the endoplasmic reticulum (ER). Cystic fibrosis is most commonly cited as the model disease: More than 1000 mutations have been identified in the gene encoding the CFTR (cystic fibrosis transmembrane conductance regulator) (Rowntree and Harris, 2003) , but the majority of the patients (~70%) have the ∆F508-mutation of the CFTR.
The resulting protein fails to reach the plasma membrane due to a stringent ER quality control mechanism, but it can function properly, if it reaches the plasma membrane (Pasyk and Foskett, 1995) . There are many more examples that lead to defective ER-export of membrane proteins; these include mutations of the V 2 -vasopressin receptor (associated with diabetes insipidus; MOL (015818) 5 5 Oksche and Rosenthal, 1998) , of the LDL-receptor (resulting in hypercholesterolemia; Hobbs et al., 1990) , of the HERG-K + -channel (resulting in long QT-syndrome-2; Kupershmidt et al., 2002) and many others. It is unclear why these mutated proteins are retained and eventually degraded although they are -at least in part -functionally active (see Pasyk and Foskett, 1995) . However, the available evidence suggests that the quality control machinery in the endoplasmic reticulum is stringent, for it prefers to err on the side of rapidly degrading a protein that -when given timemay fold into a functionally active transporter or channel.
G protein-coupled receptors have been documented to incur a folding problem: a large portion of newly synthesized protein (≥50%) is subject to degradation in the endoplasmic reticulum and does not reach the plasma membrane (Petaja-Repo et al., 2000 Pankevych et al., 2003) .
This is similar to the situation with many other membrane proteins with multiple transmembrane spans, specifically with CFTR (Rowntree and Harris, 2003) . During folding the intracellular carboxyl terminus of membrane proteins plays a prominent role, because it allows for docking of the ER-associated degradation machinery that eliminates incorrectly folded proteins. In addition, in several instances, segments within the carboxyl terminus of G protein-coupled receptors have been shown to be essential for proper folding of the protein: mutations within the carboxyl terminus of structurally unrelated G protein-coupled receptors result in receptors that fail to adopt a conformation capable of ligand binding (Krause et al., 2000; Pankevych et al., 2003; Duvernay et al., 2004) . Here we identify the de-ubiquinating enzyme Usp4 as an interaction partner of the A 2A -adenosine receptor, a prototypical G s -coupled receptor: Usp4 binds to the carboxyl terminus of the A 2A -adenosine receptor; de-ubiquitination of the receptor relaxes quality control in the ER and enhances cell surface expression. Hence, ER-associated ubiquitination is reversible, an observation that implies that quality control in the ER may be subject to dynamic regulation.
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Yeast two-hybrid interaction screen. Yeast two-hybrid analysis was performed using the MATCHMAKER yeast two-hybrid system. In this system, yeast strain EGY48 (MAT trp1 his3 ura3 leu2 6 LexAop-LEU2) was used for transformation of bait, prey, and reporter plasmids pEG202, pJG4-5 and pSH18-34, respectively. Yeast strains were grown at 30 °C in either glucose minimal medium or induction medium; transformation was performed by using lithium acetate method in accordance with manufacturer's instruction. EGY48 containing the lacZ reporter plasmid (pSH18-34) and the A 2a R ct bait plasmid (pEG202/A 2a R ct ) was transformed with prey plasmids bearing a human brain cDNA library. To verify the two-hybrid interactions, positive transformants grown on selection medium were assayed directly in situ for β-galactosidase activity assay by briefly exposure of the plates to chloroform followed by incubation with 100 µM X-gal in the medium as a substrate.
Cell culture, cellular transfection and membrane preparations. HEK293 cells were maintained in
Dulbecco´s modified Eagle medium (DMEM) at 5% CO 2, 95% air and 37°C. Culture media were supplemented with 10% fetal calf serum, 2 mM L-glutamine, β-mercaptoethanol, non-essential amino acids, 50 mg/L gentamicin and -in order to maintain the selection pressure -with 0.2 mg/mL geneticin (G418) for the culture of stably transfected cells. PC12 cells were propagated as described (Kudlacek et al., 2001) . One day before transfection, cells were replated to obtain subconfluent cultures either on glass coverslips (22 mm in diameter and placed into 6-well plates)
or 10-cm diameter cell culture dishes. Transient transfections were done using the CaPO 4 precipitation method or LipofectAMINE Plus TM (Invitrogen). When required in cotransfections with several plasmids, the appropriate empty vectors were added to keep the amount of DNA/dish constant. The medium was changed to remove excess DNA precipitates in 5 h after This article has not been copyedited and formatted. The final version may differ from this version. (100 µM chloroquine) at 37 °C for 3 h prior to harvesting. Cells were harvested and membranes were prepared as described previously (Klinger et al., 2002a) . Primary neuronal cultures were obtained from hippocampi of neonatal rats as described earlier (Boehm and Betz, 1997); four days after plating, the cultures were treated with 1 µM cytosine-β-D-arabinofuranoside (ARA-C)
to deplete glial cells. Neurons were seeded on polylysine-coated coverslips and transfected with
LipofectAMINe 2000 TM as outlined previously (Farhan et al., 2004) .
Radioligand binding assays. PC12 cells and HEK293 cells transiently transfected with the appropriate plasmids were subjected lysed by three freeze-thaw cycles followed by brief sonication; membranes were collected by centrifugation (30 min at 50,000g) as outlined previously (Klinger et al., 2002a) . Hence the particulate fraction contained intracellular membranes and the plasma membrane. Membranes were prepared from (100 µg/assay) were incubated in a final volume of 0.3 ml containing 50 mM Tris.HCl (pH 8.0), 1 mM EDTA, 5 mM (Kudlacek et al., 2001) . After the preincubation, fresh medium was added that contained 100 µM RO201724 (a non-xanthine phosphodiesterase inhibitor) and adenosine deaminase (2 U/ml) to remove any endogenously produced adenosine. After 1 h, cAMP formation was stimulated by the A 2A -selective agonist CGS21680 (1 nM to 1 µM) for 15 min and the reaction was stopped by adding 2.5% perchloric acid with 100 µM cAMP (1 ml/dish). The supernatant (0.9 ml) was aspirated, neutralized with 100 µl of 0.4 M KOH, and diluted with 1.5 ml 50 mM Tris-HCl, pH 8.0; [ 3 H]cAMP was isolated by sequential chromatography on Dowex AG 50W-X4 and neutral alumina columns. Assays were performed in triplicate.
Immunoprecipitation of the epitope-tagged A 2A -adenosine receptor. HEK293 cells stably expressing FLAG-tagged A 2A -adenosine receptor were washed three times with phosphate buffered saline; subsequently, the membranes were solubilized in ice-cold lysis buffer [50 mM Tris.HCl, pH 7.5, 1 mM EDTA, 150 mM NaCl containing 1% Nonidet P-40 (vol/vol), protease inhibitors (Complete, Roche Molecular Biochemicals) and, where indicated, 10 mM N-ethylmaleimide (NEM)] for 1 h on ice. The insoluble material was collected by centrifugation at 16,000 × g for 10 min at 4 °C. The supernatant was processed for immunoprecipitation, each step of which was conducted with constant rotation at 4 °C. Then 40 µl of a 50 % (vol/vol) suspension of anti-Flag M2 Affinity Gel was added and the sample was incubated overnight. The beads were collected by centrifugation and washed three times in 1 mL Tris-buffered saline. Immune complexes were dissociated in SDS-polyacrylamide sample buffer containing 20 mM dithiothreitol by incubation for 1 h at 37 °C or, alternatively, for 5 min at 95 °C. Proteins were transferred to nitrocellulose membranes by using a semidry transfer system; immunodetection was achieved by using monoThis article has not been copyedited and formatted. The final version may differ from this version. 
Yeast-two hybrid screen for a binding partner
Taken together, the observations summarized in Fig. 1 suggest that proteasomal degradation of the receptor is preceded by one (or several) reversible step(s) in which the receptor committed to degradation can nevertheless be rerouted to increase the number of available receptor. In order to understand the underlying mechanism, we searched for a candidate protein that bound to the carboxyl terminus of the A 2A -adenosine receptor by using the last 120 amino acids as a bait in yeasttwo hybrid interaction hunt. Because the A 2A -receptor is abundantly expressed in several brain regions, most notably the basal ganglia (Fredholm et al., 2005) , we screened a human brain library and identified more than 5 different interaction partners that reproducibly bound to the fusion protein comprising lexA and the carboxyl terminus of the A 2A -receptor. We focused on Usp4, because Usp4 is a de-ubiquinating enzyme, albeit of ill-defined function. It was the only interactor that was related to proteosomal degradation; we surmised that its deubiquinating activity may be relevant for the effects observed with the proteasome inhibitor MG132 summarized in Fig. 1 .
Usp4 is the human homolog of murine UNP (>90% amino acid identity), in spite of the eponymous description (ubiquitous nuclear protein; Gupta et al., 1994) , in all cell lines that we tested, Unp/Usp4 was found in the cytosol rather than in the nucleus (see also below). The ratio of nuclear to cytosolic distribution is dependent on the cell type (Soboleva et al., 2005) . The data shown in Fig. 1B predict that truncation of the bait construct ought to eliminate the interaction with Usp4, if there were any link between binding of Usp4 to the A 2A -receptor and the regulation of receptor levels by inhibition of proteasomal degradation. This was the case: the interaction between the Usp4-containing prey construct and the C-terminus of the A 2A -receptor induced β-galactosidase activity to levels that approached that of the constitutive and inducible controls (cf. 1 rst and 2 nd streak with 3 rd and 4 th streaks in Fig. 2A ). In contrast, truncation of the bait by 101
This article has not been copyedited and formatted. The final version may differ from this version. amino acids eliminated induction of β-galactosidase (7 th and 8 th streak in Fig. 2A ); in fact, truncation of bait by the last 52 amino acids sufficed to abolish the interaction between prey and bait (5 th and 6 th streak in Fig. 2A ). It is worth noting that other interactors were still capable of binding to the truncated bait constructs and thus to induce β-galactosidase activity to levels comparable to those seen with the wild type carboxyl terminus (Gsandtner et al., 2005) .
Interaction of the A 2A -receptor with Usp4
In order to obtain independent evidence for an interaction between the A 2A -receptor and Usp4, we coexpressed the FLAG-epitope tagged A 2A -receptor and GFP-tagged Usp4 in HEK293 cells and subjected cellular lysates to immunoprecipitation with a anti-FLAG antibody immobilized on sepharose beads. The eluate contained about 5-10% of the total Usp4 -as detected by an antiserum directed against GFP -provided that Usp4 and the A 2A -receptor were coexpressed (Fig. 2B, lane 3 
USP4 enhances the cell surface expression of the A 2A -receptor
As mentioned above, in living cells, a large portion of A 2A -adenosine receptors was visualized within the cell rather than at the plasma membrane (Fig. 3A) . This was true irrespective of whether stably or transiently transfected cells were employed. If Usp4 was co-expressed, the A 2A -receptor level in the membrane increased at the expense of the intracellular fraction of the receptor (Fig. 3B) . The following observations show that the effect of Usp4 was specific: (i) It was not mimicked by coexpression of another deubiquitinating enzyme, Usp14 (Fig. 3C ). Usp14
is the functional homolog of yeast Ubp6p, associates with the 26S proteasome complex (Borodovsky et al., 2001; Chernova et al., 2003) and is apparently specific for monoubiquitinated substrates (Wilson et al., 2002) . (ii) We employed another G protein-coupled receptor that has a high propensity to accumulate within the cell, namely the type-5 metabotropic glutamate receptor (mGluR5); CFP-tagged mGluR5 was predominantly found within the transfected cells, regardless of whether the receptor was expressed in the absence (Fig. 3D ) or presence of Usp4 (Fig. 3E) or Usp14 (Fig. 3F) . (iii) Based on the yeast two-hybrid screen (see Fig. 2A (Fig. 3G,H) nor of the A 2A -receptor(1-311) (Fig. 3I,J ). Finally, we tested the effect of combining expression of Usp4 and inhibition of proteosomal degradation. MG132 ought to relax quality control and thus allow the receptor to escape from the endoplasmic reticulum.
Addition of the proteasome inhibitor MG132 augmented the amount of receptor at the cell surface (cf. Fig. 3K and Fig. 3A) ; in the presence of both, Usp4 and MG132, essentially all of the receptor was found at the cell surface (Fig. 3L) .
In order to test whether endogenous levels of Usp4 sufficed to regulate cell surface expression of A 2A -receptors, we employed RNA-interference. We were not successful in reducing mRNA levels for Usp4 by RNA-interference in PC12 cells (three primers tested). When expressed at levels comparable to those seen in PC12 cells or in striatal membranes, the A 2A -receptor accumulates in large amounts within HEK293 cells (see Fig. 3A ). Under these conditions, RNA-interference is unlikely to yield any detectable increment in intracellular accumulation. Therefore, we selected a HEK 293 cell line that expressed A 2A -receptors at low levels. In these cells the A 2A -receptor is predominantly found at the plasma membrane (Fig. 4B) . Of several siRNAs, siRNA2
caused a significant reduction in the mRNA encoding Usp4 (Fig. 4A ). In cells, in which Usp4 mRNA had been lowered by RNA-interference (cf. Fig. 4A ), the A 2A -receptor appeared within the cell (Fig. 4C) .
USP4 raises the cell surface level of A 2A -receptors in hippocampal neurons
The intracellular accumulation of the A 2A -receptor in HEK293 cells may arise from the fact that these cells do not endogenously express the receptor and are more likely to retain the receptor.
USP4 is abundantly expressed in hippocampus, striatum and PC12 cells (Fig. 4D) . We therefore This article has not been copyedited and formatted. The final version may differ from this version. (Rosin et al. 1998) , and visualized the distribution of receptors in living cells in the absence and presence of co-expressed GFP-tagged Usp4. In the absence of Usp4, the A 2A -receptor was mainly found within the soma (Fig. 5A) . Coexpression of Usp4 (visualized in Fig. 5C ) increased the level of the fluorescence at the cell surface (Fig. 5B) . In contrast, the presence of Usp4 (visualized in Fig. 5F ) did not enhance the cell surface level of the truncated version A 2A -receptor(1-311), which was predominantly detected within the somata of the neurons (cf. Fig. 5D and 5E). Finally, we also visualized CFP-tagged mGluR5 which was found within the neuronal soma (Fig. 5G) ; the coexpression of Usp4 (visualized in Fig. 5I ) did not lead to the appearance of mGluR5 at the cell surface (Fig. 5H) .
Coexpression of Usp4 results in the accumulation of deubiquitinated A 2A -receptor
In order to show that Usp4 utilized the A 2A -receptor as substrate, we transiently cotransfected HEK293 cells with plasmids encoding the Flag-tagged A 2A -receptor, HA-tagged ubiquitin and GFP-tagged Usp4. The A 2A -receptor was immunoprecipitated with anti-Flag antibodies from detergent lysates of cells that either coexpressed only HA-tagged ubiquitin (Fig. 6A, lanes 1,2) or the combination of HA-tagged ubiquitin and Usp4 (Fig. 6B, lanes 4,5) : Receptor bands were detected with anti-Flag antibody (blots shown on top); in the absence of Usp4, the FLAG-reactive immunostaining was seen in the range of ~48-50 kDa (Fig. 6A top, lanes 1,2) ; in the presence of Usp4, the FLAG-tagged receptor migrated at ~40-42 kDa (Fig. 6B top, lanes 1,2) . Lanes 3 and 6 represent the negative controls, that is immunoprecipitation was carried out with cellular lysates that lacked the A 2A -adenosine receptor but contained HA-tagged ubiquitin and -in lane 6 -Usp4.
Regardless of the conditions, immunoreactivity was neither recovered in the ~40-42 kDa nor in the ~48-50 kDa range. Thus, the immunostaining was specific. The nitrocellulose membranes This article has not been copyedited and formatted. The final version may differ from this version. were stripped and stained with anti-HA antibodies (Fig. 6A&B, bottom blots) . In cells cotransfected with the plasmids encoding the Flag tagged A 2A -receptor and HA-tagged ubiquitin, the HAantibody stained a ~48-50 kDa band. This corresponded to the ubiquitinated form of the A 2A -receptor, because this band was also stained with the anti-HA antibody (cf. Fig. 6A top and bottom blots). In contrast, when coexpressed with Usp4, the A 2A -receptor, which migrated as a band of 40-42 kDa (Fig. 5B , top, lanes 4&5), was not detected with the anti-HA antibody (Fig. 6B, bottom, lanes 4&5). This band therefore represents the deubiquitinated species of the receptor.
Coexpression of USP4 increases the surface expression of A 2A -receptors
As documented in Fig. 3 , Usp4 caused a redistribution of the CFP-tagged A 2A -receptor to the cell surface. Two scenarios can be envisaged: Usp4 enhances ER-export of the de novo synthesized A 2A -receptor. Alternatively, the A 2A -receptor may undergo rapid constitutive endocytosis such that -even in the absence of agonist -a high proportion of the receptor is found within the cell at steady state. By contrast with newly synthesized receptors which are either en route to the Golgi or to ER-associated degradation, recycling receptors have already passed through the Golgi; thus, they ought to be fully glycosylated. As can be seen from Fig. 6C and D, the bulk of the A 2A -receptor that was recovered from cellular lysates was cleaved by endoglycosidase H (Fig. 6C &   D , cf. first and second left hand lanes and set of bars respectively). However, in cells that coexpressed Usp4, the A 2A -receptor became resistant to deglycosylation by endoglycosidase H (Fig. 6C & D, cf. third and fourth lanes and set of bars respectively). Thus, the presence of Usp4 allows the A 2A -receptor to escape the endoplasmic reticulum and rapidly traffic through the Golgi to the plasma membrane.
It is conceivable that relaxing quality control by coexpressing Usp4 allowed unfolded receptors to
This article has not been copyedited and formatted. The final version may differ from this version. representative saturation curves are shown in Fig. 7B ; B max averaged from several saturation experiments are shown in the bar diagram in Fig. 7C .
The model of quality control in the endoplasmic reticulum predicts that all steps are reversible provided that the carboxyl terminus of the membrane protein has not yet been engulfed by the proteasome (Kostova and Wolf, 2003) . Accordingly the action of Usp4 and of proteasome inhibition is expected to be additive. This was the case. As can be seen from the average B maxvalues summarized in Fig. 7C ., sole addition of MG132 caused a pronounced increase in the amount of A 2A -receptor binding sites. This was associated with a substantial increase in ubiquitinated receptor (inset in Fig. 7C ). The combined presence of both, Usp4 and MG132 resulted in an even more dramatic increase in the number of receptors.
This article has not been copyedited and formatted. The final version may differ from this version. Fig. 8A ), the agonist CGS21680 elicited a larger maximum effect than in cells that only expressed the A 2A -adenosine receptor (circles in Fig. 8A ). We stress that this is not a non-specific effect that can, for instance, be accounted for by an increased responsiveness of the catalytic moiety of adenylyl cyclase in the presence of Usp4. Control experiments revealed that cells expressing solely the A 2A -receptor or the A 2A -receptor and Usp4
did not differ in their responsiveness to forskolin (Fig. 8B ). When expressed in HEK293 cells, the A 2A -receptor displays some appreciable constitutive activity, which is magnified in the presence of forskolin (Klinger et al., 2002a) . Accordingly, the antagonist ZM241385 (1 µM) was included to eliminate any possible confounding effect, which may result from the fact that A 2A -receptor levels differ substantially in the absence and presence of coexpressed Usp4.
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DISCUSSION
The family of deubiquitinating enzymes (acronym = DUB) is categorized into three subfamilies, the smaller ubiquitin C-terminal hydrolase (UCH) subfamily, the larger ubiquitin-specific processing protease (USP/UBP) subfamily and recently described subfamily of OTU-domain containing proteins. UCH enzymes are generally small, containing only a proteolytic core domain that functions to cleave small molecular weight adducts from the ubiquitin C-terminus. In contrast, USPs/UBPs -such as Usp4 -are physically much larger and contain substantial and divergent sequences beyond their catalytic core. The analysis of genomic sequences predicts the presence of more than 90 deubiquinating enzymes in a given mammalian genome (Chung and Baek, 1999) , the vast majority of which belong to the USP/UBP-family. In fact, cDNAs have recently been cloned that encode 22 additional members of the human USP-family (Quesada et al., 2004) . While the catalytic activity has been tested using artificial substrates, very little is known about their physiological substrates and thus their physiological functions. In fact, the number of identified substrates is remarkably small: the largest list exists for fat facets/FAM/USP9X, which deubiquitinates the ras effector AF-6 (Taya et al., 1998) , β-catenin (Taya et al., 1999) , Liquid facets (a drosophila homolog of the mammalian endocytotic protein epsin, Chen et al., 2002) and Vasa (an RNA-helicase, Liu et al., 2003) . The substrates of the mammalian enzymes USP7/HAUSP (herpes virus associated USP) and USP2a are p53 (Li et al., 2002) and fatty acid synthase (Gadner et al., 2004) , respectively. Membrane-embedded receptors, in general, and G protein-coupled receptors, in particular, are subject to ubiquitination (Hicke, 1999 , Wojcikiewicz, 2004 . However, to the best of our knowledge, specific deubiquitination reactions have not yet been reported for transmembrane receptors: the A 2A -receptor is the first example of a G proteincoupled receptor which is shown to be a specific substrate for a deubiquinating enzyme of the USP/UBP-family.
This article has not been copyedited and formatted. The final version may differ from this version. In many instances, deubiquinating enzymes accelerate proteasomal degradation by removing ubiquitin from proteasome-bound substrate or proteolytic intermediates thereof. Deubiquinating enzymes may thereby allow the proteasome to engulf the substrate more efficiently and to operate at the maximal rate. However, there is also precedent for an antagonism between proteasomal degradation and deubiquinating enzymes: the developmental defect, which is caused by fat facet mutants in the drosophila compound eye, can be suppressed by a reduction in proteosomal activity (Huang et al., 1995) . Similarly, USP7/HAUSP prevents the degradation of p53 ( (Wilson et al., 2002) ; the absence of the metabotropic glutamate receptor-1 (mGluR1), a G qcoupled receptor, also causes ataxia in mice (Aiba et al., 1994) . We thus surmised that Usp14 may act on group I mGluRs, which it did not. More importantly, Usp14 did not affect the subcellular distribution of the A 2A -receptor. Thus, raising deubiquinating activity in the cell did not per se suffice to enhance the accumulation of the A 2A -receptor at the cell surface.
Ubiquitination plays a prominent role in supporting endocytosis of membrane receptors (Hicke, 1999) . A more recent survey of several GPCRs indicates that ubiquitination can either target the receptors during biosynthesis to proteasomal degradation or redirect them on the endocytotic pathway to the lysosome (Wojcikiewicz, 2004) . Our experiments were not designed to address a possible role of Usp4 in regulating the rate of endocytosis of the A 2A -receptor and it is conceivable that Usp4 also affects the rate of receptor recycling. It is, however, unlikely that the effects observed in the present study are accounted for by a Usp4-induced inhibition of endocytosis. Firstly, endocytosed receptors are still capable of binding antagonist radioligands. In contrast, a large fraction of newly synthesized receptor in the endoplasmic reticulum fails to bind antagonist with appreciable affinity (Pankevych et al., 2003) . Thus, the finding that Usp4 (and of the proteasome inhibitor) raised the level of antagonist binding is consistent with an action during synthesis and subsequent quality control in the ER. Secondly, coexpression of Usp4 affected the proportion of receptor that was resistant to the action of endoglycosidase H: in the absence of Usp4, the bulk of the receptor was sensitive to deglycosylation by endoglycosidase H and, thus,
had not yet been delivered to the Golgi apparatus. In contrast, in the presence of Usp4 a substantial portion of the receptor was resistant to endoglycosidase H and had thus left the ER-compartment and trafficked through the Golgi. Finally, our experiments were done in the absence of agonist, i.e. under conditions where endocytosis of G protein-coupled receptors is not prominent.
This article has not been copyedited and formatted. The final version may differ from this version. Similar to other misfolded membrane proteins, incorrectly folded G protein-coupled receptors are retrotranslocated through the sec61 translocon and degraded by the proteasome (Petaja-Repo, 2001 ). The latter step is contingent on ubiquitination. From a teleological perspective, it appears most plausible to target the carboxyl terminus of a G protein-coupled receptor for ubiquitination.
This allows for cotranslational quality control because the accumulation of misfolded intermediates can be sensed and trigger the ubiquitination of the carboxyl terminus that is still tethered to the Sec61 channel. Point mutations are known to render G protein-coupled receptors more prone to misfold. Mutations in the V 2 -vasopressin receptor, which lead to diabetes insipidus, are among the most prominent examples (Oksche and Rosenthal, 1998) . Attempts to rescue these mutant receptors have been originally inspired by non-specific manipulations that were successful in CFTR, including DMSO, glycerol and other polyols, trimethylamine-N-oxide and phenylbutyrate (Gelman and Kopita, 2002) . G protein-coupled receptors, however, have the advantage that folding may be aided by receptor ligands provided that they are membrane permeable (Bernier et al., 2004) . The current observations suggest another mechanism that may represent a viable alternative, namely to target the deubiquinating enzyme that can recognize the receptor as a substrate. As shown here for the A 2A -receptor, this approach is -in principle -also capable of rescuing a receptor from ER-associated degradation and of thereby increasing its cell surface level. We assume that the current observations are of relevance for G protein-coupled receptors, in general, and for other membrane proteins that are subject to stringent quality control in the endoplasmic reticulum.
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